Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, ChronicInterventions: Drug: Sitagliptin; Drug: Glipizide; Drug: Placebo for Sitagliptin; Drug: Placebo for GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2007 Category: Research Source Type: clinical trials
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
Conditions: Diabetes Mellitus, Type 2; End-Stage Kidney DiseaseInterventions: Drug: Sitagliptin; Drug: GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2007 Category: Research Source Type: clinical trials